# Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors

> **NCT00502892** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 2 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** Topotecan
- **DRUG:** Ifosfamide
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00502892
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2012-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502892, "Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00502892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*